Log in to save to my catalogue

Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes

Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1789034084

Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes

About this item

Full title

Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes

Publisher

New York: Springer US

Journal title

Current gastroenterology reports, 2016-07, Vol.18 (7), p.32-32, Article 32

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Treatment with direct-acting antiviral agents has revolutionized the approach to hepatitis C. We are now able to obtain high sustained virological response (SVR) rates, even in the historically difficult-to-treat patient populations. SVR translates into improved clinical outcomes, particularly overall and liver-related mortality, and benefits are m...

Alternative Titles

Full title

Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1789034084

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1789034084

Other Identifiers

ISSN

1522-8037

E-ISSN

1534-312X

DOI

10.1007/s11894-016-0508-y

How to access this item